Triptans and CGRP blockade - impact on the cranial vasculature

Area of Science:

• Neuroscience
• Pharmacology
• Vascular Biology

Background:

• The trigeminovascular system is central to migraine pathophysiology.
• Serotonin and calcitonin gene-related peptide (CGRP) are key neuropeptides involved in migraine pain and vascular changes.

Purpose of the Study:

• To review the effects of triptans and CGRP antagonists on human cranial vasculature.
• To assess the relevance of these vascular effects for migraine treatment.

Main Methods:

• Literature review of studies on triptans and CGRP antagonists.
• Focus on human studies examining cranial vasculature.

Main Results:

• Triptans and CGRP antagonists impact cranial vasculature.
• The perivascular space is a potential site of action for anti-migraine drugs and migraine triggers.

Conclusions:

• Understanding the vascular effects of migraine medications is crucial.
• Further investigation into the precise mechanisms of triptans and CGRP antagonists is warranted for optimized migraine therapy.